References
- 1. Bot JC, Barkhof F, Lycklama a Nijeholt G, et al. Differentiation of multiple sclerosis from other infl ammatory disorders and cerebrovascular disease: Value of spinal MR imaging. Radiology. 2002;223:46-56.10.1148/radiol.2231010707
- 2. Sahraian MA, Radue EW-MRI. Gadolinium enhancing lesions in multiple sclerosis, in Atlas of MS lesions. Springer-Verlag, Berlin, 2008, 45-65.10.1007/978-3-540-71372-2_3
- 3. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 1991;180(2):467-474.10.1148/radiology.180.2.2068314
- 4. Lucchinetti CF, Brück WB, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathology. 1996;6(3):259-274.10.1111/j.1750-3639.1996.tb00854.x
- 5. Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Multiple Sclerosis.2007;13(7):884-894.10.1177/1352458507076970
- 6. He J, Grossman RI, Ge Y, Mannon LJ - Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol. 2001;22: 664-669.
- 7. Yousry I, Filippi M, Walther E, Gasperini C, Capra R, Yousry, TA. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose. Magn Reson Imaging. 2000;18(9):1183-1186.10.1016/S0730-725X(00)00191-0
- 8. Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to Gadolinium-containing iv contrast media in children and adults. Americal Journal of Roengenology. 2007;189(6):1533-1538.10.2214/AJR.07.255418029897
- 9. Trop I, Bourgouin PM, Lapierre Y, et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. AJNR Am J Neuroradiol. 1998;19:1025-1033